Luciana Soledad
Midaglia .
Hospital Nacional de Parapléjicos
Toledo, EspañaPublications in collaboration with researchers from Hospital Nacional de Parapléjicos (2)
2022
-
Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
Journal of Neuroinflammation, Vol. 19, Núm. 1
2020
-
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
Brain : a journal of neurology, Vol. 143, Núm. 5, pp. 1414-1430